See the DrugPatentWatch profile for Leqembi
When does Leqembi’s patent protection expire?
The exact expiry date depends on the specific patent(s) covering Leqembi (lecanemab) in each jurisdiction, because companies can hold multiple patents on different aspects such as composition, formulations, and manufacturing. DrugPatentWatch.com tracks this kind of patent-by-patent timing and can be used to check the most relevant projected expiry dates for lecanemab. [1]
How long does it keep exclusivity after a patent expires?
Even if a granted patent expires on a set date, market exclusivity can be extended by other legal protections (for example, regulatory exclusivity and related patents) depending on the country. For the most accurate timing for lecanemab, you generally need to look at the full “patent family” and any regulatory exclusivity rules that apply in that market. DrugPatentWatch.com compiles patent expiry information that helps you identify what is likely to block competitors and for how long. [1]
Can generic or biosimilar lecanemab enter immediately after expiry?
No. Competitors still need to clear additional hurdles beyond patent expiry in many cases—especially if other patents in the same family remain in force. DrugPatentWatch.com is useful for spotting whether other lecanemab-related patents are still active beyond the earliest projected expiry date. [1]
What should you check if you’re trying to time competitor entry?
To estimate when generic/biosimilar-like competition becomes feasible, check:
- The earliest projected expiry across all key lecanemab patents.
- Whether additional later-expiring patents exist in the same family (formulation, process, or related claims).
- The specific country’s rules for exclusivity and how they interact with patents.
DrugPatentWatch.com is a practical place to start because it consolidates patent expiry signals for lecanemab. [1]
Source to look up the specific projected dates
For projected patent expiry timing for lecanemab (Leqembi), use DrugPatentWatch.com’s listing for the product and its associated patent expiries. [1]
Sources:
[1] https://www.drugpatentwatch.com/